Skip to main
University-wide Navigation

A new, lifesaving product aimed at reducing the death toll from heroin abuse—developed by professor Daniel Wermeling at the University of Kentucky College of Pharmacy—is in its final round of clinical trials and has received Fast Track designation by the Food and Drug Administration.

Video and press release regarding the Nasal Spray.

Credits

Produced by Alicia P. Gregory, videography/direction by Chad Rumford (Research Communications).